Alexion Pharmaceuticals Raises FY20 Adj. EPS Guidance From $10.45-10.75 To $10.65-$10.95 vs $10.88 Est., Raises Sales Guidance From $5.23B-$5.33B To $5.55B-$5.6B vs $5.41B Est.